RGDXQ (RGDXQ) Stock Price & Analysis
RGDXQ (RGDXQ) rose 0.00% to USD 0 as of June 10, 2026 at 12:18 UTC, according to Nexqual real-time market data.
RGDXQ last closed at USD 0; the session ranged USD 0–0 on volume of 77,000 shares. Market capitalization is $1,365, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 12:18 UTC.
Key Statistics (as of June 10, 2026 at 12:18 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 77,000 shares |
| Market Cap | $1,365 |
| Exchange | PNK |
Technical Analysis (RGDXQ)
Nexqual's technical model rates RGDXQ "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 12:18 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (RGDXQ)
Wall Street analysts rate RGDXQ "None", per Nexqual as of June 10, 2026 at 12:18 UTC.
| Consensus Rating | None |
|---|
Earnings (RGDXQ)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2014-03-31 | USD -0.09 vs est -0.05 ▼ miss |
| 2013-12-31 | USD -0.09 vs est -0.07 ▼ miss |
| 2013-09-30 | USD -0.08 vs est -0.07 ▼ miss |
| 2013-06-30 | USD -0.04 vs est -0.04 ▲ beat |
Source: Nexqual, June 10, 2026 at 12:18 UTC.
Financials & Fundamentals (RGDXQ)
| Total Revenue | $16.62M |
|---|---|
| Revenue Growth (YoY) | -2.70% |
| Gross Margin | +37.60% |
| Operating Margin | -96.05% |
| Profit Margin | -85.54% |
| Current Ratio | 1.8 |
| Total Cash | $1.73M |
| Total Debt | $10.94M |
| Free Cash Flow | $-8.11M |
Source: Nexqual, June 10, 2026 at 12:18 UTC.
Financial Health Score (RGDXQ)
Nexqual rates RGDXQ's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 12:18 UTC.
| Growth | Solid — Revenue +6% YoY (annual) |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Mixed — $2M cash vs $11M debt |
| Cash Flow | Weak — FCF negative: -$8M, burning cash |
| Efficiency | Mixed — No data |
Ownership (RGDXQ)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 13.65M |
| Short % of Float | +0.31% |
Source: Nexqual, June 10, 2026 at 12:18 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| TNGNQ | TENGION INC | USD 0 | ▲ 0% |
| ROSGQ | ROSETTA GENOMICS LTD | USD 0 | ▲ 0% |
| PZRXQ | PHASERX INC | USD 0 | ▲ 0% |
| PFND | PATHFINDER CELL THERAPY INC | USD 0 | ▲ 0% |
| GNLKQ | GENELINK INC | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 12:18 UTC. This page is informational and not investment advice.